Management of Osteomyelitis in Sickle Cell Disease: Review Article. (September 2020)

• Record Type: Journal Article
• Authors: Al Farii, Humaid; Zhou, Sarah; Albers, Anthony
• Is Part Of: Journal of the AAOS. Volume 4:Number 9(2020)
• Publication Date: 2020-09
• Subjects: Orthopedic surgery -- Periodicals; 617.4705
• DOI: 10.5435/JAAOSGlobal-D-20-00002
• Languages: English
• ISSNs: 2474-7661

Abstract

Abstract : Sickle cell disease (SCD) is an autosomal recessive disorder that is characterized by abnormal "sickle-shaped" erythrocytes. Because of their shape, these erythrocytes are more likely to become trapped in small slow-flowing vessels, leading to vaso-occlusion. Because this commonly happens in the bones, patients with SCD are at an increased risk for orthopaedic manifestations such as osteomyelitis, septic joint, or osteonecrosis. Osteomyelitis is a serious and potentially disabling condition but can be difficult to differentiate from benign conditions of SCD, such as vaso-occlusive crisis. Diagnosis of osteomyelitis requires careful evaluation of the clinical presentation, laboratory testing, and imaging. Treatment of osteomyelitis in patients with SCD may be medical or surgical, but considerations in antibiotic selection and management preoperatively and postoperatively must be taken to ensure optimal outcomes.